1. Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences and Neuroscience, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States
2. Department of Urology and Center for Clinical Research, University Freiburg Medical Center, Freiburg 79106, Germany
3. Structural Genomics Consortium, Botnar Research Center, NIHR Oxford BRU, University of Oxford, Oxford OX3 7LD, U.K.
4. Institute of Pharmaceutical Sciences, University of Freiburg, Freiburg 79104, Germany
5. Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K.; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K.
6. Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada
7. Ontario Institute for Cancer Research, 661 University Avenue, Toronto, Ontario M5G 0A3, Canada
8. Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada
9. Princess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1L7, Canada
10. German Cancer Research Centre (DKFZ), Heidelberg 69120, Germany
11. German Cancer Consortium (DKTK), Freiburg 79104, Germany
12. Botnar Research Centre, University of Oxford, Oxford OX3 7LD, U.K.
13. Oxford Translational Myeloma Centre, University of Oxford, Oxford OX3 7LD, U.K.
14. CIBSS Centre of Biological Signalling Studies, University of Freiburg, Freiburg 79106, Germany